Tirzepatide 30mg

$105.00

Tirzepatide 30mg (TR30) by LP Peptides is a premium lyophilized research peptide supplied in 30mg × 10 vials per box. As a dual GLP-1 and GIP receptor agonist, TR30 is widely studied in metabolic, obesity, glucose regulation, and endocrine research. Produced with batch-specific quality documentation, it is intended exclusively for qualified laboratory research and not for human or veterinary use.

Description

Tirzepatide 30mg (TR30) – Research Peptide

Product InformationDetails
Product NameTirzepatide 30mg (TR30)
BrandLP Peptides
SKUTR30
CategoryWeight Loss & Metabolic Research
Research CompoundTirzepatide
Specification30mg × 10 Vials / Box
FormLyophilized Powder
AvailabilityResearch Use Only
PriceContact for Current Pricing

What is TR30?

Tirzepatide 30mg (TR30) is a premium-quality research peptide supplied by LP Peptides for qualified laboratory applications. Tirzepatide is an investigational dual incretin receptor agonist that acts on both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors. Its dual mechanism has made it one of the most extensively researched compounds for studies involving metabolism, glucose regulation, appetite signaling, and energy balance.

Researchers utilize Tirzepatide in metabolic and endocrine studies to investigate receptor signaling, insulin sensitivity, glucose homeostasis, and obesity-related pathways. LP Peptides provides TR30 as a high-quality 30mg × 10 vials per box lyophilized powder with batch-specific quality documentation for laboratory research.


Product Specifications

SpecificationDetails
ProductTirzepatide 30mg
SKUTR30
BrandLP Peptides
CompoundTirzepatide
Strength30mg
Packaging30mg × 10 Vials / Box
FormLyophilized Powder
CategoryWeight Loss & Metabolic Research
Intended UseLaboratory Research Only

Research Applications

Tirzepatide is commonly investigated in laboratory research involving:

  • GLP-1 receptor signaling
  • GIP receptor signaling
  • Glucose metabolism
  • Insulin sensitivity
  • Appetite regulation
  • Energy expenditure
  • Weight management research
  • Obesity models
  • Type 2 diabetes research
  • Metabolic pathway studies

Research should always be performed using validated laboratory protocols and documented procedures.


Frequently Compared Research Peptides

Researchers frequently compare TR30 with related metabolic research peptides, including:

Related Products
TR10
TR20
RT10
RT20
RT30

Each research compound should be evaluated individually according to the study protocol and laboratory objectives.


Reconstitution Reference

Handling InformationReference
DiluentBacteriostatic Water
Recommended Volume1.0 mL
Approximate Concentration30 mg/mL
PreparationSlowly add bacteriostatic water down the vial wall using sterile technique. Gently swirl until fully dissolved. Avoid vigorous shaking or foaming.
Laboratory HandlingRecord the final concentration and preparation date before laboratory use.

Storage Guidelines

Storage ConditionRecommendation
Lyophilized PowderStore at −20°C (−4°F) or below in a dry, dark environment.
Reconstituted SolutionStore at 2–8°C (36–46°F), protect from light, and use within approximately 4 weeks.
HandlingAllow the sealed vial to reach room temperature before opening to minimize condensation.

Laboratory Handling

For consistent laboratory practice:

  • Use sterile preparation techniques.
  • Add diluent slowly along the vial wall.
  • Gently swirl until completely dissolved.
  • Avoid excessive agitation or foaming.
  • Record preparation date and concentration.
  • Refrigerate after reconstitution.
  • Follow laboratory SOPs and batch-specific documentation.

Research Safety Information

Researchers commonly monitor study parameters involving:

  • Gastrointestinal tolerance
  • Appetite signaling
  • Glucose regulation
  • Energy metabolism
  • Insulin response
  • Hydration status

Ongoing scientific research continues to evaluate the pharmacological profile of Tirzepatide in controlled laboratory settings.


Research Use Disclaimer

TR30 supplied by LP Peptides is intended strictly for laboratory research purposes.

This product:

  • Is not intended for human use.
  • Is not intended for veterinary use.
  • Is not intended for consumption.
  • Should only be handled by qualified laboratory professionals.

COA & Quality Assurance

Every LP Peptides batch undergoes quality verification before distribution.

Researchers should verify each batch using:

Quality Checklist
Certificate of Analysis (COA)
Batch Number
Product Identity Verification
HPLC Purity (where applicable)
Testing Date
Sterility Testing (where applicable)
Endotoxin Testing (where applicable)
Residual Solvent Analysis
Storage & Handling Documentation

Frequently Asked Questions

QuestionAnswer
Is TR30 supplied for research use only?Yes. TR30 is intended exclusively for qualified laboratory research and is not for human or veterinary use.
How can I verify the product quality?Review the current Certificate of Analysis (COA), batch number, and quality documentation before laboratory use.
Can TR30 be compared with other research peptides?Yes. Researchers commonly compare TR30 with TR10, TR20, RT10, RT20, and RT30 depending on the study objectives.
Why can scientific publications differ from product documentation?Scientific literature provides general compound information, while LP Peptides documentation reflects current batch-specific specifications, testing, and handling procedures.

Customer Reviews

RatingSummary
⭐⭐⭐⭐⭐Excellent packaging and detailed batch documentation.
⭐⭐⭐⭐⭐Product arrived securely packaged and matched the listed specifications.
⭐⭐⭐⭐⭐Reliable quality and consistent ordering experience.
⭐⭐⭐⭐☆Clear labeling and comprehensive laboratory documentation.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 30mg”

Your email address will not be published. Required fields are marked *

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.